Answer
Reboxetine passes into breast milk at anticipated very low levels, but risk to the nursing infant cannot be excluded, so use during breast-feeding can be considered only if potential benefits outweigh the risk to the child.
Sources for this answer
- Edronax 4mg TabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 27Document updated
Sources checked